Serum glutamine, set-shifting ability and anorexia nervosa

Annals of General Psychiatry

Volumn 9, Issue , 2010, Pages

  Nakazato, Michiko ^a,b   Hashimoto, Kenji ^c   Schmidt, Ulrike ^a   Tchanturia, Kate ^a   Campbell, Iain C ^a   Collier, David A ^a   Iyo, Masaomi ^b,d   Treasure, Janet ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; GLYCINE; SERINE;

ADULT; AMINO ACID BLOOD LEVEL; ANOREXIA NERVOSA; ANXIETY DISORDER; ARTICLE; BODY MASS; CLINICAL ARTICLE; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; NEUROTRANSMISSION; PSYCHOLOGIC TEST; WISCONSIN CARD SORTING TEST;

EID: 77954642218     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-9-29     Document Type: Article

References (38)

1. Roberts M, Tchanturia K, Stahl D, Southgate L, Treasure J. A systematic review and meta-analysis of set-shifting ability in eating disorders. Psychosom Med 2007, 37:1075-1084.
2. Lopez C, Tchanturia K, Stahl D, Treasure J. Weak central coherence in eating disorders: a step towards looking for an endophenotype of eating disorders. J Clin Exp Neuropsychol 2009, 31:117-125. 10.1080/13803390802036092, 18608648.
3. Tchanturia K, Morris R, Anderluh B, Collier D, Nikolaou V, Treasure J. Set shifting in anorexia nervosa: an examination before and after weight gain, in full recovery and relationship to childhood and adult OCPD traits. J Psychiatr Res 2004, 38:545-552. 10.1016/j.jpsychires.2004.03.001, 15380406.
4. Tchanturia K, Campbell I, Morris R, Treasure J. Neuropsychological studies in anorexia nervosa. Int J Eat Disord 2005, 37(Suppl):72-76. 10.1002/eat.20119, 15690471.
5. Holliday J, Tchanturia K, Landau S, Collier D, Treasure J. Is impaired set-shifting an endophenotype of anorexia nervosa?. Am J Psychiatry 2005, 162:2269-2275. 10.1176/appi.ajp.162.12.2269, 16330590.
6. Wobrock T, Ecker UK, Scherk H, Schneider-Axmann T, Falkai P, Gruber O. Cognitive impairment of executive function as a core symptom of schizophrenia. World J Biol Psychiatry 2009, 10:442-451. 10.1080/15622970701849986, 18609418.
7. Sachs G, Schaffer M, Winklbaur B. Cognitive deficits in bipolar disorder. Neuropsychiatr 2007, 21:93-101.
8. Rao NP, Reddy YC, Kumar KJ, Kandavel T, Chandrashekar CR. Are neuropsychological deficits trait markers in OCD?. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1574-1579. 10.1016/j.pnpbp.2008.05.026, 18582524.
9. Snitz BE, Macdonald AW, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 2006, 32:179-194. 10.1093/schbul/sbi048, 2632195, 16166612.
10. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009, 113:1-20. 10.1016/j.jad.2008.06.009, 18684514.
11. Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B, Gillberg C, Leboyer M, Bourgeron T, . Paris utism Research International Sibpair (PARIS) Study Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 2002, 7:302-310. 10.1038/sj.mp.4000979, 2547854, 11920157, Paris utism Research International Sibpair (PARIS) Study.
12. McGale EH, Pye IF, Stonier C, Hutchinson EC, Aber GM. Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem 1977, 29:291-297. 10.1111/j.1471-4159.1977.tb09621.x, 886334.
13. Alfredsson G, Wiesel FA, Tylec A. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers. Biol Psychiatry 1988, 23:689-97. 10.1016/0006-3223(88)90052-2, 2453224.
14. Castro-Fornieles J, Bargalló N, Lázaro L, Andrés S, Falcon C, Plana MT, Junqué C. Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy. J Psychiatr Res 2007, 41:952-958. 10.1016/j.jpsychires.2006.09.013, 17112540.
15. Ohrmann P, Kersting A, Suslow T, Lalee-Mentzel J, Donges US, Fiebich M, Arolt V, Heindel W, Pfleiderer B. Proton magnetic resonance spectroscopy in anorexia nervosa: correlations with cognition. Neuroreport 2004, 15:549-553. 10.1097/00001756-200403010-00033, 15094521.
16. Nicolle MM, Baxter MG. Glutamate receptor binding in the frontal cortex and dorsal striatum of aged rats with impaired attentional set-shifting. Eur J Neurosci 2003, 18:3335-3342. 10.1111/j.1460-9568.2003.03077.x, 14686906.
17. Goff D, Coyle J. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001, 158:1367-1377. 10.1176/appi.ajp.158.9.1367, 11532718.
18. Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 2003, 60:572-576. 10.1001/archpsyc.60.6.572, 12796220.
19. Roberts AC, Robbins TW, Everitt BJ, Muir JL. A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in marmosets. Neuroscience 1992, 47:251-264. 10.1016/0306-4522(92)90241-S, 1641123.
20. Stefani MR, Groth K, Moghaddam B. Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. Behav Neurosci 2003, 117:728-737. 10.1037/0735-7044.117.4.728, 12931958.
21. Darrah JM, Stefani MR, Moghaddam B. Interaction of N-methyl-d-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm. Behav Pharmacol 2008, 19:225-234. 10.1097/FBP.0b013e3282feb0ac, 18469540.
22. Roser W, Bubl R, Buergin D, Seelig J, Radue EW, Rost B. Metabolic changes in the brain of patients with anorexia and bulimia nervosa as detected by proton magnetic resonance spectroscopy. Int J Eat Disord 1999, 26:119-136. 10.1002/(SICI)1098-108X(199909)26:2<119::AID-EAT1>3.0.CO;2-M, 10422601.
23. Schlemmer HP, Möckel R, Marcus A, Hentschel F, Göpel C, Becker G, Köpke J, Gückel F, Schmidt MH, Georgi M. Proton magnetic resonance spectroscopy in acute, juvenile anorexia nervosa. Psychiatry Res 1998, 82:171-179. 10.1016/S0925-4927(98)00019-5, 9754441.
24. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, Washington DC: American Psychiatric Press, 4, American Psychiatric Association.
25. Fairburn C, Beglin S. Assessment of eating disorders: interview or self-report questionnaire?. Int J Eat Disord 1994, 16:363-370.
26. Hodgson R, Rachman S. Obsessional-compulsive complains. Behav Res Ther 1977, 15:389-395. 10.1016/0005-7967(77)90042-0, 612339.
27. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
28. Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindström L, Iyo M. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC Psychiatry 2005, 31:6.
29. Yamada K, Ohnishi T, Hashimoto K, Ohba H, Iwayama-Shigeno Y, Toyoshima M, Okuno A, Takao H, Toyota T, Minabe Y, Nakamura K, Shimizu E, Itokawa M, Mori N, Iyo M, Yoshikawa T. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels. Biol Psychiatry 2005, 57:1493-1503. 10.1016/j.biopsych.2005.03.018, 15953485.
30. Fukushima T, Kawai J, Imai K, Toyo'oka T. Simultaneous determination of d- and l-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection. Biomed Chromatogr 2004, 18:813-819. 10.1002/bmc.394, 15386574.
31. Heaton RK, Chelune GJ, Talley JL, Kay G, Curtiss G. Wisconsin Card Sorting Test. Computer version 1993, Psychological Assessment Resources, Odessa FL, 4.
32. Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol 1955, 19:393-394. 10.1037/h0044509, 13263471.
33. Küçükibrahimothomampersand E, Saygin MZ, Calişkan M, Kaplan OK, Unsal C, Gören MZ. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. Eur J Clin Pharmacol 2009, 65:571-577. 10.1007/s00228-009-0650-7, 19373461.
34. Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR, Kawahara R. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1155-1158. 10.1016/j.pnpbp.2006.03.036, 16707201.
35. Kravariti E, Morris RG, Rabe-Hesketh S, Murray RM, Frangou S. The Maudsley Early Onset Schizophrenia Study: cognitive function in adolescent-onset schizophrenia. Schizophr Res 2003, 65:95-103. 10.1016/S0920-9964(03)00067-7, 14630302.
36. He Y, Hakvoort TB, Koehler SE, Vermeulen JL, de Waart DR, de Theije C, Ten Have GA, van Eijk HM, Kunne C, Labruyere WT, Houten SM, Sokolovic M, Ruijter JM, Deutz NE, Lamers WH. Glutamine synthetase in muscle is required for glutamine production during fasting and extrahepatic ammonia detoxification. J Biol Chem 2010, 285:9516-9524. 10.1074/jbc.M109.092429, 20064933.
37. Kerruish KP, O'Connor J, Humphries IR, Kohn MR, Clarke SD, Briody JN, Thomson EJ, Wright KA, Gaskin KJ, Baur LA. Body composition in adolescents with anorexia nervosa. Am J Clin Nutr 2002, 75:31-37.
38. Zastrow A, Kaiser S, Stippich C, Walther S, Herzog W, Tchanturia K, Belger A, Weisbrod M, Treasure J, Friederich HC. Neural correlates of impaired cognitive-behavioral flexibility in anorexia nervosa. Am J Psychiatry 2009, 166:608-616. 10.1176/appi.ajp.2008.08050775, 19223435.